We are live on ! Find out more
NHC icon

National Healthcare

82 hedge funds and large institutions have $273M invested in National Healthcare in 2014 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 29 increasing their positions, 27 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

4% more funds holding

Funds holding: 7982 (+3)

7% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 27

1% more capital invested

Capital invested by funds: $269M → $273M (+$3.9M)

0.72% less ownership

Funds ownership: 35.5%34.78% (-0.72%)

Holders
82
Holders Change
+3
Holders Change %
+3.8%
% of All Funds
2.36%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
29
Reduced
27
Closed
1
Calls
Puts
Net Calls
Net Calls Change

NHC Hedge Fund Activity: Q1 2014 in Review

82 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in National Healthcare (NHC) for Q1 2014, worth a combined $273M — up 1.4% from $269M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new NHC positions and 1 closed out — a net gain of 3 holders — while 29 added to existing stakes and 27 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $1.48M. The largest seller was Brown Brothers Harriman & Co, cutting an estimated $6.18M.

  • 82 institutional investors held National Healthcare (NHC) as of Q1 2014, up from 79 in Q4 2013.
  • Funds reported $273M of National Healthcare stock for Q1 2014, up 1.4% quarter-over-quarter.
  • 4 funds opened new National Healthcare positions in Q1 2014 and 1 closed out, a net change of +3 holders.
  • The largest National Healthcare buyer in Q1 2014 was JP Morgan Chase, an estimated $1.48M added.
  • The largest National Healthcare seller in Q1 2014 was Brown Brothers Harriman & Co, an estimated $6.18M sold.

Based on aggregated 13F filings for Q1 2014.